Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Gastroenterology

Filter By Diseases (0)

How much time do you have? in mins

All Content

68
Summaries

Real-world evaluation of Tegoprazan vs. Rabeprazole in H. pylori...

Both Tegoprazan and Rabeprazole-based therapies are equally effective and safe in eradicating H. pylori.

48
Medical News

Tobacco, Alcohol, Coffee: Genetics reveal their role in hepatobil...

Considering genetic factors is pivotal in understanding how lifestyle choices impact health, guiding future public health recommendations in avoi...

46
Medical News

Statins show promise in cutting long-term risks for liver disease...

In MASLD, statins significantly reduce the long-term risk of death, liver-linked complications, and worsening of liver stiffness.

129
Medical News

IBS and diet: How structured support makes restrictive eating wor...

Structured support aids irritable bowel syndrome patients on restrictive diets, but personalized options are key for long-term success.

200
Patient Education

Understanding Pain Scales: What Do They Really Mean?

Pain is described as a bothersome feeling that affects both your body and emotions.

129
Medical News

Postprandial Amoxicillin improves VA-dual therapy outcomes for H....

Postprandial dosing and higher Amoxicillin frequency may improve Vonoprazan-Amoxicillin dual therapy efficacy, particularly for H. pylori rescue...

254
Medical News

Coenzyme-Q10 improves vascular and myocardial health in MASLD pat...

Using high-dose coenzyme-Q10 for six months effectively alleviates liver steatosis and improves vascular and heart function in MASLD-affected peo...

262
Summaries

Tegoprazan for functional dyspepsia: A multicenter trial on effic...

Tegoprazan (50 mg), a potassium-competitive acid blocker, is effective and safe for treating functional dyspepsia, offering prominent symptom rel...

374
Medical News

Statins cut fibrosis risk in MASLD patients: New findings!

Both high and moderate-intensity statins show a protective effect against fibrosis deterioration in MASLD.

303
Medical News

Tongxieyaofang eases IBS through CHRM3 regulation and gut barrier...

The decoction of Tongxieyaofang alleviates irritable bowel syndrome symptoms by influencing CHRM3 and gut barrier function.

229
Summaries

Evaluation of antimicrobial concentrations in gastric tissues for...

Optimizing the levels and distribution of antibacterial drugs in the gastric mucosa is crucial for achieving effective H. pylori elimination rate...

316
Medical News

Study reveals new findings for erosive esophagitis therapy

Potassium-competitive acid blockers are safe and effective, especially for 2-week short-term use, severe erosive esophagitis, and maintenance the...

Try: